Cholesterol in Nanobiotechnology

Philipp Schattling, Yan Zhang, Boon M Teo, Brigitte Städler

Research output: Chapter in Book/Report/Conference proceedingEncyclopaedia / Dictionary EntryOtherpeer-review

Abstract

Cholesterol is an essential and natural component of animal cells. The human body contains approximately 140g of cholesterol, which is found mainly in cellular membranes. Since its first recognition during the late eighteenth century, cholesterol has evolved from an alcohol-soluble side fraction of human gallstones into a compound with an extraordinary impact on nanobiotechnology. Such remarkable development is based on two key facts: (i) the intrinsic chemical and physical properties of the steroid skeleton; and (ii) the advent of modern polymerization techniques which enable the design of sophisticated polymeric architectures with significant impact on nanomedicine. The contributions made by cholesterol in the fields of liposomal drug delivery, biosensing and cell mimicry will be discussed in this chapter, with emphasis placed on the design and strategic access to cholesterol-containing polymer structures.
Original languageEnglish
Title of host publicationEncyclopedia of Molecular Cell Biology and Molecular Medicine
EditorsRobert A Meyers
PublisherWiley-Blackwell
Number of pages52
Publication statusAccepted/In press - 2017

Cite this

Schattling, P., Zhang, Y., Teo, B. M., & Städler, B. (Accepted/In press). Cholesterol in Nanobiotechnology. In R. A. Meyers (Ed.), Encyclopedia of Molecular Cell Biology and Molecular Medicine Wiley-Blackwell.
Schattling, Philipp ; Zhang, Yan ; Teo, Boon M ; Städler, Brigitte. / Cholesterol in Nanobiotechnology. Encyclopedia of Molecular Cell Biology and Molecular Medicine. editor / Robert A Meyers. Wiley-Blackwell, 2017.
@inbook{da6c03f307194999822fc349fb5c7e0d,
title = "Cholesterol in Nanobiotechnology",
abstract = "Cholesterol is an essential and natural component of animal cells. The human body contains approximately 140g of cholesterol, which is found mainly in cellular membranes. Since its first recognition during the late eighteenth century, cholesterol has evolved from an alcohol-soluble side fraction of human gallstones into a compound with an extraordinary impact on nanobiotechnology. Such remarkable development is based on two key facts: (i) the intrinsic chemical and physical properties of the steroid skeleton; and (ii) the advent of modern polymerization techniques which enable the design of sophisticated polymeric architectures with significant impact on nanomedicine. The contributions made by cholesterol in the fields of liposomal drug delivery, biosensing and cell mimicry will be discussed in this chapter, with emphasis placed on the design and strategic access to cholesterol-containing polymer structures.",
author = "Philipp Schattling and Yan Zhang and Teo, {Boon M} and Brigitte St{\"a}dler",
year = "2017",
language = "English",
editor = "Meyers, {Robert A}",
booktitle = "Encyclopedia of Molecular Cell Biology and Molecular Medicine",
publisher = "Wiley-Blackwell",
address = "Australia",

}

Schattling, P, Zhang, Y, Teo, BM & Städler, B 2017, Cholesterol in Nanobiotechnology. in RA Meyers (ed.), Encyclopedia of Molecular Cell Biology and Molecular Medicine. Wiley-Blackwell.

Cholesterol in Nanobiotechnology. / Schattling, Philipp; Zhang, Yan; Teo, Boon M; Städler, Brigitte.

Encyclopedia of Molecular Cell Biology and Molecular Medicine. ed. / Robert A Meyers. Wiley-Blackwell, 2017.

Research output: Chapter in Book/Report/Conference proceedingEncyclopaedia / Dictionary EntryOtherpeer-review

TY - CHAP

T1 - Cholesterol in Nanobiotechnology

AU - Schattling, Philipp

AU - Zhang, Yan

AU - Teo, Boon M

AU - Städler, Brigitte

PY - 2017

Y1 - 2017

N2 - Cholesterol is an essential and natural component of animal cells. The human body contains approximately 140g of cholesterol, which is found mainly in cellular membranes. Since its first recognition during the late eighteenth century, cholesterol has evolved from an alcohol-soluble side fraction of human gallstones into a compound with an extraordinary impact on nanobiotechnology. Such remarkable development is based on two key facts: (i) the intrinsic chemical and physical properties of the steroid skeleton; and (ii) the advent of modern polymerization techniques which enable the design of sophisticated polymeric architectures with significant impact on nanomedicine. The contributions made by cholesterol in the fields of liposomal drug delivery, biosensing and cell mimicry will be discussed in this chapter, with emphasis placed on the design and strategic access to cholesterol-containing polymer structures.

AB - Cholesterol is an essential and natural component of animal cells. The human body contains approximately 140g of cholesterol, which is found mainly in cellular membranes. Since its first recognition during the late eighteenth century, cholesterol has evolved from an alcohol-soluble side fraction of human gallstones into a compound with an extraordinary impact on nanobiotechnology. Such remarkable development is based on two key facts: (i) the intrinsic chemical and physical properties of the steroid skeleton; and (ii) the advent of modern polymerization techniques which enable the design of sophisticated polymeric architectures with significant impact on nanomedicine. The contributions made by cholesterol in the fields of liposomal drug delivery, biosensing and cell mimicry will be discussed in this chapter, with emphasis placed on the design and strategic access to cholesterol-containing polymer structures.

M3 - Encyclopaedia / Dictionary Entry

BT - Encyclopedia of Molecular Cell Biology and Molecular Medicine

A2 - Meyers, Robert A

PB - Wiley-Blackwell

ER -

Schattling P, Zhang Y, Teo BM, Städler B. Cholesterol in Nanobiotechnology. In Meyers RA, editor, Encyclopedia of Molecular Cell Biology and Molecular Medicine. Wiley-Blackwell. 2017